Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Bone marrow is the preferred site of memory CD4+ T cell proliferation during recovery from sepsis
Tomasz Skirecki, Patrycja Swacha, Grażyna Hoser, Jakub Golab, Dominika Nowis, Ewa Kozłowska
Tomasz Skirecki, Patrycja Swacha, Grażyna Hoser, Jakub Golab, Dominika Nowis, Ewa Kozłowska
View: Text | PDF
Research Article Immunology Infectious disease

Bone marrow is the preferred site of memory CD4+ T cell proliferation during recovery from sepsis

  • Text
  • PDF
Abstract

Sepsis survivors suffer from increased vulnerability to infections, and lymphopenia presumably contributes to this problem. The mechanisms of the recovery of memory CD4+ T cells after sepsis remain elusive. We used the cecal ligation and puncture mouse model of sepsis to study the restoration of the memory CD4+ T cells during recovery from sepsis. Then, adoptive transfer of antigen-specific naive CD4+ T cells followed by immunization and BrdU labeling were performed to trace the proliferation and migration of memory CD4+ T cells. We revealed that the bone marrow (BM) is the primary site of CD4+ memory T cell homing and proliferation after sepsis-induced lymphopenia. Of interest, BM CD4+ T cells had a higher basal proliferation rate in comparison with splenic T cells. These cells also show features of resident memory T cells yet have the capacity to migrate outside the BM niche and engraft secondary lymphoid organs. The BM niche also sustains viability and functionality of CD4+ T cells. We also identified IL-7 as the major inducer of proliferation of the BM memory CD4+ T cells and showed that recombinant IL-7 improves the recovery of these cells. Taken together, we provide data on the mechanism and location of memory CD4+ T cell proliferation during recovery from septic lymphopenia, which are of relevance in studying immunostimulatory therapies in sepsis.

Authors

Tomasz Skirecki, Patrycja Swacha, Grażyna Hoser, Jakub Golab, Dominika Nowis, Ewa Kozłowska

×

Figure 2

BM contains actively proliferating CD4+ T cells after sepsis.

Options: View larger image (or click on image) Download as PowerPoint
BM contains actively proliferating CD4+ T cells after sepsis.
(A) Experi...
(A) Experimental design. Mice underwent CLP surgery and subsequent treatment with antibiotic and fluid resuscitation. On day 6 or 13 after surgery, mice were injected with a bolus of BrdU i.p. Twenty-four hours later the cells were isolated from organs and analyzed by flow cytometry. (B) Representative flow cytometry plots showing CD4+BrdU+ cells that were actively cycling after BrdU administration. Upper row shows plots from sham animals, and lower row shows plots from 7 days post-CLP mice. (C) Percentage of BrdU+ cells among CD4+ T cells from different organs at given time points after CLP (n = 6–8 in each group); box-and-whiskers plot presents p25-p75 (box), mean, and p10-p90 (whiskers). ****P < 0.0001 between BM and lymph nodes or spleen; §§§§P < 0.0001 between BM 7 days after CLP and control or 14 days post-CLP using ANOVA with Tukey’s multiple-comparisons test. (D) Changes in the subset composition of CD4+ T cells that incorporated BrdU. Data from 2 independent experiments are shown (n = 6–8). Superimposed graphs: sign on the left side of bar represents P < 0.05 between day 7 and control; sign on the right side of bar represents P < 0.05 between days 14 and 7. “*” represents differences between effector; “&” effector memory; “#” central memory; and “§” naive CD4+ T cells at different time points using ANOVA with Tukey’s post hoc test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts